← All stocks

Climb Bio, Inc.

CLYM Net buying

CIK 0001768446 #2557 in the set updated 19 Sep 2026

Bought (12 mo)

$779.63K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.65M

$2.65M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 6 sales

Net

−$1.87M

+$779.63K against sales at will

By person

4 insiders · 9 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Thomas Stephen Basil

Director

—

$2.25M (5) scheduled

−$2.25M

467,969

0.8148%

$6.40M

−9.5%

RA CAPITAL MANAGEMENT, L.P. entity

Director

$779.63K (3)

—

+$779.63K

3,403,429

5.93%

$46.52M

−85.5%

Brennan Aoife

President and CEO

—

$406.98K (1) scheduled

−$406.98K

87,731

0.1527%

$1.20M

+4,910%

Pimblett Emily

SVP, Finance & CAO

—

18,888

0.0329%

$258.16K

+115.7%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 21

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 20,508,750

History held since 11 Aug 2021